Bacteriol 2004, 186:3480–3491 PubMedCrossRef 10 Le Loi


Bacteriol 2004, 186:3480–3491.PubMedCrossRef 10. Le Loir Y, Baron F, Gautier M: Staphylococcus aureus and food poisoning. Genet Mol Res 2003, 2:63–76.PubMed eFT508 clinical trial 11. Lowy FD: Staphylococcus aureus infections. N Engl J Med 1998,339(8):520–532.PubMedCrossRef 12. Davis SL, Perri MB, Donabedian SM, Manierski C, Singh A, Vager D, Haque NZ, Speirs K, Muder RR, Robinson-Dunn B, Hayden MK, Zervos MJ: Epidemiology and outcomes of community-associated methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 2007,45(6):1705–1711.PubMedCrossRef 13. Loeffler JM, Nelson D, Fischetti VA: Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase. Science 2001, 294:2170–2172.PubMedCrossRef 14. Nelson D, Loomis L, Fischetti VA: Prevention and elimination of upper respiratory colonization of mice by group A streptococci by using a bacteriophage lytic enzyme. Proc Natl Acad SC79 Sci USA 2001,98(7):4107–4112.PubMedCrossRef 15. Yoong P, Schuch R, Nelson D, Fischetti VA: Identification of a broadly active phage lytic enzyme with lethal activity against antibiotic-resistant Enterococcus faecalis and Enterococcus faecium . J Bacteriol 2004,186(14):4808–4812.PubMedCrossRef 16. Zimmer M, Vukov N, Scherer S, Selumetinib order Loessner M: The murein hydrolase of the bacteriophage phi3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl Environ Microbiol

2002,68(11):5311–5317.PubMedCrossRef 17. Cheng Q, Nelson D, Fischetti VA: Removal of group B streptococci colonizing the vaginal and oropharynx of mice with a bacteriophage

lytic enzyme. Antimicrob Agents Chemother 2005,49(1):111–117.PubMedCrossRef 18. Schuch R, Nelson D, Fischetti VA: A bacteriolytic enzyme that detects and kills Bacillus anthracis . Nature 2002, 418:884–889.PubMedCrossRef 19. Becker SC, Dong S, Baker JR, Foster-Frey J, Pritchard DG, Donovan DM: LysK CHAP endopeptidase GPCR & G Protein inhibitor domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett 2009,294(1):52–60.PubMedCrossRef 20. Manoharadas S, Witte A, Bläsi U: Antimicrobial activity of a chimeric enzybiotic towards Staphylococcus aureus . J Biotechnol 2009, 139:118–123.PubMedCrossRef 21. Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA: Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus . Antimicrob Agents Chemother 2010, 54:1603–1612.PubMedCrossRef 22. García P, Madera C, Martínez B, Rodríguez A: Biocontrol of Staphylococcus aureus in curd manufacturing processes using bacteriophages. Int Dairy J 2007, 17:1232–1239.CrossRef 23. García P, Martinez B, Obeso JM, Lavigne R, Lurz R, Rodríguez A: Functional genomic analysis of two Staphylococcus aureus phages isolated from the dairy environment. Appl Environ Microbiol 2009,75(24):7663–7673.PubMedCrossRef 24.

Comments are closed.